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Abstract
Objectives: Understanding why some women actively decline cervical screening could contribute to tailored intervention
development. We explored reasons for non-participation in cervical screening among women who had made an active decision
not to attend in the future. We also explored interest in human papillomavirus self-sampling.
Methods: In a population-based survey of women in Great Britain, home-based computer-assisted interviews were carried out
with screening eligible women. Women reported their intention to attend for screening when next invited. They endorsed
predefined barriers to screening and indicated their interest in human papillomavirus self-sampling.
Results:Women who had actively declined screening and those who intended to go but were currently overdue (n=543) were
included in this analysis. Women who had made an active decision not to be screened in the future were more likely to endorse
the barriers ‘I have other more important things to worry about’ and to perceive screening to be of low relevance based on
their sexual behaviour. Most participants (70%) indicated that they would be interested in human papillomavirus self-sampling.
Interest in self-sampling was greater among those who reported having had a bad experience of screening in the past, were too
busy or embarrassed to attend, or would not want a man to carry out the test.
Conclusions: Women who had made an active decision not to attend screening felt it was of low relevance to them and that
they had more important things to worry about. Shifting the perceived cost–benefit ratio for these women by offering human
papillomavirus self-sampling might increase screening participation in this group.
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Introduction
In the United Kingdom, women aged 25–64 are regularly
invited for cervical screening as part of the NHS Cervical
Screening Programme.1 The programme is a cost-free,
call–recall service, and all women registered with a
General Practitioner (GP), regardless of whether they
attended screening when previously invited, are invited
for screening every three (25- to 49-year-olds) or five
years (50- to 64-year-olds). Since the cervical screening
programme began in 1988, it has been estimated that up
to 5000 cervical cancer deaths a year have been prevented
due to screening in England and Wales.2 However, the
proportion of eligible women being screened has declined
from 76% in 2011 to 72% in 2017.3 Identifying the reasons
why women do not attend for screening is important, to
develop effective interventions to improve informed
uptake. Studies exploring screening non-attendance using
qualitative and quantitative methods suggest a wide
range of barriers, including practical barriers such
as difficulties arranging appointments,4 emotional barriers
including embarrassment and fear of what the test might
find,5 and low perceived risk of cervical cancer.5–7
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The Precaution Adoption Process Model (PAPM) sug-
gests that individuals move through a series of stages
towards participating in a given health behaviour, while
acknowledging that some non-participants will actively
decide not to participate.8 We recently used the PAPM
to determine the prevalence of different cervical screening
non-participant types.9 This research found that most non-
participants were aware of screening and had made a deci-
sion about future attendance. The majority of these
intended to go for screening despite currently being over-
due or unscreened, but some had made an active decision
not to attend for screening in future (15% of all non-
participants). Exploring the reasons why some women
have chosen not to attend screening would help to
inform the development of tailored interventions for this
group. If a woman has made an informed choice not to
attend, this is to be respected, but if the decision is based
on misconceptions (e.g. about risk), or relates to aspects of
the procedure that are perceived as aversive (e.g. the spec-
ulum examination) or inconvenient, appropriate interven-
tions could potentially overcome these barriers.
Numerous studies have explored barriers to
cervical screening in the United Kingdom4,5,10 and
beyond,7,11,12 but previous research focusing on the rea-
sons why individuals actively decide not to attend cervical
screening is limited. Blomberg et al.13 explored why
women did not wish to participate in a population-based
cervical screening programme at present, or in the future,
in Stockholm, Sweden. Fax messages detailing the reasons
for declining screening, and a small number of telephone
interviews were analysed qualitatively. A lack of confi-
dence in the benefits of screening, low perceived risk of
cervical cancer, and a belief in one’s ability to detect
health changes via symptoms were the most commonly
described reasons for choosing not to be screened.13 The
study also found that previous negative experiences of
screening, or health care in general, contributed to the
decision.13 Another Swedish qualitative study found that
women who actively chose not to be screened were aware
of the benefits of screening, but did not feel that they
needed screening because they felt healthy and did not
think their personal risk of getting cervical cancer was
high.14 Low self-esteem, a negative body image, and antic-
ipated discomfort were also discussed, and by choosing not
to attend screening, women felt that they could avoid a
situation in which they felt vulnerable.14 Finally, women
commented that they had a number of demands on their
time, such as work or childcare, so as long as they felt
healthy, screening was not considered a priority.14
One way of overcoming some of the practical and emo-
tional barriers to cervical screening may be to offer human
papillomavirus (HPV) self-sampling. HPV is a common
sexually transmitted infection,15 and nearly all cases of
cervical cancer can be attributed to an HPV infection.16
HPV self-sampling allows women to collect a sample of
cells, which can then be sent to a laboratory and tested
for HPV. While it is not currently offered by the NHS
Cervical Screening Programme, a number of studies have
suggested that self-sampling for HPV is acceptable to
women,17–20 and a recent review found that offering
HPV self-sampling increased participation by around
10% in screening non-attenders.21 Another study explor-
ing previous barriers to screening, among women who had
been overdue for screening but carried out an HPV self-
test, found that both practical and emotional barriers had
played a role in why they had not attended GP-based
screening.22
The main aims of the study were to (1) explore self-
reported barriers to cervical screening among women
who have made an active decision not to attend in the
future, compared with those who intended to be screened;
and (2) assess whether HPV self-sampling would be accept-
able to these women, and whether this alternative method
addressed specific barriers to screening.
Methods
Data were collected as part of a larger survey of non-
attendance at cervical screening.9 Fieldwork was carried
out by a market research agency (TNS) as part of their
regular Omnibus survey. Data were collected using face-to-
face computer-assisted personal interviews with screening
eligible women (i.e. aged 25–64) in Great Britain. Overall,
3112 eligible women took part and provided sufficient data
for their future screening intention to be determined. Only
women who were classified as non-participants were asked
additional questions about their attitudes to screening.
Measures
Past screening behaviour: Past screening behaviour was
assessed using three questions. Women who had not
either had a hysterectomy or been diagnosed with
cervical cancer were asked ‘Have you ever heard of cervical
screening, also known as the smear test or Pap test?’ (yes,
no, don’t know). Those who responded yes to this question
were then asked ‘Have you ever had a cervical screening
test?’ (yes, no, don’t know) followed, if applicable, by
‘When was the last time you had a cervical screening
test?’ (within the last three years, 3–5 years ago, longer
than five years, don’t know). Using these three items and
accounting for the participant’s age (which determines
their recommended screening interval), women were
coded as ‘never screened’, ‘up-to-date’, or ‘overdue’.
Intention to attend cervical screening in future: Future
intention to be screened was assessed using the question
‘Do you intend to go when next invited?’ (Yes, no, don’t
know). Those who responded ‘Yes’ were coded as ‘intend-
ers’ and those who responded ‘no’ were coded as
‘active decliners’.
Barriers to screening: Women who were classified as
overdue or who did not plan to attend screening in the
future were presented with a predefined list of barriers to
screening, and the instruction ‘There are many reasons
why women don’t go for screening. Do any of these
apply to you?’. Sixteen barriers were presented in random-
ized order (to reduce response bias). The barriers were
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adapted from previous studies of cervical screening4,5,23,24
and were designed to assess a range of reasons why women
may not attend screening, including perceived relevance
and value, previous experiences, and practical barriers.
Women were asked to select as many reasons as applica-
ble. If none of the options were applicable, women could
select ‘other’ and type in their reason. Where a woman had
selected ‘other’ and written a reason that related to one of
the 16 predefined barriers it was recoded as that barrier
following discussion between two authors (n¼ 9).
Six of the 16 barriers (‘I have never been sexually active
so I don’t need screening’, ‘I am no longer sexually active
so I don’t need screening’, ‘I’ve been with the same partner
for a long time so I don’t need screening’, ‘I have only ever
been with one partner so I don’t need screening’, ‘I’ve only
ever had sex with women so I don’t need screening’, and ‘I
currently only have sex with women so I don’t need screen-
ing’) related to the perception that cervical screening was
of low relevance because of their sexual behaviour. A new
variable was derived whereby women endorsing at least
one of these six barriers were coded as endorsing ‘Low
perceived relevance based on sexual behaviour’.
Self-sampling: Interest in self-sampling was assessed
using the question ‘In the future, it may be possible for
women to do the test themselves at home, using a vaginal
swab (similar to a cotton bud). Would you prefer this
option?’ (yes definitely, yes probably, probably not, defi-
nitely not, don’t know). This was recoded into a binary
variable with those responding ‘yes’ (probably or definite-
ly) coded as being interested in self-sampling, and those
responding ‘probably not’, ‘definitely not’, or ‘don’t know’
coded as not being interested in self-sampling.
Sociodemographic variables: Sociodemographic varia-
bles were collected using items designed by TNS or
based on the 2011 census. These included age, marital
status, working status, and social grade. Social grade rep-
resented the occupation of the Chief Income Earner in the
household: AB managerial/professional, C1 supervisory,
C2 skilled manual, D semi-skilled/unskilled manual, E
casual/lowest grade workers.25 Ethnicity was assessed
using the 2011 census question.26 Responses were col-
lapsed into the following: White British or Irish, White
Other, South Asian, Black, Mixed, or other
ethnic background.
Analysis
Analyses were carried out using SPSS v23. The PAPM
model describes how people first become aware of and
engaged with the idea of screening before making a deci-
sion about attending and then translating this into action.
We were interested in reasons for non-participation in cer-
vical screening among women who had made an active
decision about whether to attend in the future (i.e. explor-
ing the post-decision-making part of the PAPM, before
intention is translated into action) and have therefore
included in the current analyses women who were consid-
ered to be ‘intenders’ (were intending to be screened, but
currently overdue for screening) or ‘active decliners’ (had
decided not to be screened in the future).
Univariate logistic regression models were used to
explore whether being an active decliner (versus an intend-
er) was associated with: (i) sociodemographic factors or (ii)
specific barriers to screening. Variables that were signifi-
cant at the p< 0.05 level were entered into a multivariate
logistic regression model to explore the adjusted effects.
We used chi-square tests to explore differences in inter-
est in HPV self-sampling between women who were
intenders and active decliners, and logistic regression to
see if endorsing any particular barriers was associated
with interest in HPV self-sampling. As the focus of this
paper was the comparison of two subgroups, rather than
reporting the group distributions, we used
unweighted data.
Results
Of the 3112 eligible women who completed the survey, 14%
(n¼ 426) were classified as intenders and 4% (n¼ 117) were
classified as active decliners (The remaining women were
maintainers (i.e. up to date and intending to be screened
in the future), unaware of, unengaged with, or undecided
about screening. More detail of the overall distribution of
non-participants is reported elsewhere.7). Characteristics of
the sample in the current analyses and sociodemographic
correlates of being an active decliner are shown in Table 1.
Endorsement of barriers to screening
The proportion of women endorsing each of the barriers to
screening is presented in Table 2. All women endorsed at
least one of the 16 predefined barriers or an ‘other’ barrier
(n¼ 543). Most women endorsed just one (n¼ 465), 51
women endorsed two, and 27 women endorsed three or
more barriers. Active decliners were significantly more
likely than intenders to report two (15% versus 8%,
p¼ 0.01) or three or more barriers (9% versus 4%,
p¼ 0.03). Just over 70% of women (n¼ 395) endorsed at
least one of the 16 predefined barriers to screening. The
most frequently endorsed barriers were being too busy to
go for screening (16%), low relevance due to sexual behav-
iour (15%), embarrassment (12%), not having been invited
to screening (12%), fear of what the test might find (10%),
concerns about a man carrying out screening (8%), and
having had a bad experience of screening in the past (8%).
In addition to the 16 predefined barriers, 27% of women
reported an ‘other’ barrier (n¼ 149). Most of these (70%)
were unspecific, with no reason provided (e.g. ‘none apply’,
‘no reason’), 15% reported that they would or did go for
screening, and 15% reported various miscellaneous bar-
riers. Intenders were more likely to report an ‘other’ bar-
rier than active decliners (31% versus 15%, p¼ 0.001).
Univariate logistic regression analyses were used to
explore the association between endorsing each barrier
and being an active decliner. Being an active decliner was
associated with increased odds of endorsing the barriers ‘I
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am too old to go for screening’ (endorsed by 9% of active
decliners versus 3% of intenders), ‘I have other more
important things to worry about than screening’ (12%
versus 2%), ‘I’ve had a bad experience of screening in
the past’ (14% versus 7%), ‘I have weighed up the risks
and benefits and decided it’s not worth me going for
screening’ (13% versus 1%), and at least one barrier
included in ‘low relevance due to sexual behaviour’ (27%
versus 12%). Active decliners were at decreased odds of
endorsing the barrier ‘I haven’t been invited to cervical
screening’ (4% versus 14% of intenders).
Age, marital status, and the six barriers to screening
that were significantly associated with being an active
decliner were entered into a multivariate logistic regression
model (see Table 2). After adjusting for age and marital
status, endorsing the barriers ‘I am too old to go for
screening’ and ‘I’ve had a bad experience of screening in
the past’ were no longer significantly associated with being
an active decliner; however, endorsing ‘I have other more
important things to worry about than screening’ remained
significant (p< 0.001), as did ‘I have weighed up the risks
and benefits and decided it’s not worth me going for
screening’ (p< 0.001), ‘I haven’t been invited to cervical
screening’ (p¼ 0.033), and endorsing at least one barrier
related to ‘low relevance due to sexual behav-
iour’ (p< 0.001).
Interest in using self-sampling
Of the intenders, 70% reported that they would prefer to
do the test themselves at home (47% ‘definitely’ and 23%
‘probably’). Of the active decliners, 66% reported that they
would prefer to do the test themselves at home (43% ‘def-
initely’ and 23% ‘probably’). There was no difference in
overall preference for self-sampling between intenders and
active decliners (v2(1, N¼ 539)¼0.281, p¼ 0.60).
Univariate logistic regression analyses were used to explore
whether a preference for self-sampling was associated with
endorsement of specific barriers to screening (see Figure 1).
Endorsement of four barriers was significantly associated
with greater preference for self-sampling: ‘I am too busy to
go for screening’ (OR¼ 2.63, 95% CI: 1.44–4.82), ‘I
Table 1. Sociodemographic characteristics of the sample and correlates of being an active decliner.
Characteristics of
the total sample
(n¼ 543)
Proportion of active
decliners in each
demographic subgroup
(n¼ 117)
Unadjusted odds
ratio for being an
active decliner
Adjusted odds ratio
for being an active
declinerþþ
n (column %þ) n (row %) OR (95% CI) OR (95% CI)
Age (years)
25–34 188 (34.6) 21 (11.2) 1.00 1.00
35–44 159 (29.3) 25 (15.7) 1.48 (0.80–2.77) 1.15 (0.58–2.27)
45–54 115 (21.2) 22 (19.1) 1.88 (0.98–3.60) 1.44 (0.71–2.94)
55–64 81 (14.9) 49 (60.5) 12.18 (6.45–23.00)*** 7.46 (3.58–15.53)***
Social grade
AB: managerial/professional 84 (15.5) 17 (20.2) 1.00
C1: supervisory 154 (28.4) 35 (22.7) 1.16 (0.60–2.23)
C2 skilled manual 108 (19.9) 18 (16.7) 0.79 (0.38–1.64)
D: semi-skilled/unskilled manual 106 (19.5) 23 (21.7) 1.09 (0.54–2.21)
E: casual/lowest grade workers 91 (16.8) 24 (26.4) 1.41 (0.70–2.87)
Ethnicity
White British/Irish 390 (72.2) 87 (22.3) 1.00
Any other White 52 (9.6) 12 (23.1) 1.05 (0.53–2.08)
South Asian 52 (9.6) 8 (15.4) 0.63 (0.29–1.40)
Black 29 (5.4) 6 (20.7) 0.91 (0.36–2.30)
Mixed/other 17 (3.1) 2 (11.8) 0.46 (0.10–2.07)
Working status
Working full-time 179 (33) 40 (22.3) 1.00
Working part-time 141 (26) 24 (17.0) 0.71 (0.41–1.25)
Not working 223 (41.1) 53 (23.8) 1.08 (0.68–1.73)
Marital status
Married 329 (60.6) 50 (15.2) 1.00 1.00
Single 143 (26.3) 37 (25.9) 1.95 (1.21–3.15)** 2.44 (1.39–4.28)**
Previously marriedþþþ 71 (13.1) 30 (42.3) 4.08 (2.34–7.14)*** 3.54 (1.79–7.03)***
Previous screening status
Ever been screened 360 (66.3) 83 (23.1) 1.00
Never been screened 181 (33.3) 34 (18.8) 0.77 (0.49–1.21)
þ Due to rounding up or down, percentages may not add up to 100%.
þþ Adjusted analyses includes all sociodemographic characteristics significant in unadjusted analyses; **p< 0.01, ***p< 0.001.
þþþ Includes women who are separated, divorced, and widowed.
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wouldn’t want a man to carry out the test’ (OR¼ 2.38,
95% CI: 1.04–5.47), ‘I’ve had a bad experience of screening
in the past’ (OR¼ 2.97, 95% CI: 1.23–7.17), and ‘I am too
embarrassed to go for screening’ (OR¼ 1.99, 95% CI:
1.03–3.85).
Discussion
This study explored differences in self-reported barriers to
cervical screening among women who had formed inten-
tions about attending screening in the future, comparing
women who intended to attend for screening with those
who had decided not to. Women in both groups endorsed
a wide range of barriers, but we identified some barriers
that were more commonly reported by active decliners.
In line with previous research,13,14 women who had
decided not to be screened were twice as likely to endorse
barriers relating to ‘low perceived relevance based on
sexual behaviour’. While women may feel they are less at
risk of developing cervical cancer because of their current
sexual behaviour, it has been suggested that it can take
between 10 and 20 years for cervical cancer to develop
from an HPV infection,27 so a woman’s current sexual
behaviour does not necessarily reflect her current risk.
Efforts should be made to ensure all women have access
to relevant risk information to enable a fully informed
choice. This might include clarifying common misconcep-
tions about the link between sexual behaviour and HPV,
and emphasizing that any sexual contact could expose a
woman to HPV, a woman could have HPV for many years
without knowing it, and it could take many years for cer-
vical cancer to develop. This information could be added
to the information leaflet that is sent to all women who are
invited for NHS cervical screening.
Women who had decided not to be screened were also
more likely to endorse the barrier ‘I have other more
important things to worry about’ than women who were
intending to be screened. Previous findings have shown
that having other things to worry about is a key reason
why women choose not to attend cervical screening, as
long as they feel healthy.14 While women who had decided
not to be screened were more likely to say that they had
weighed up the risks and benefits of screening, this state-
ment was only endorsed by 13% of active decliners.
Deciding not to attend screening is a legitimate choice,
but it is important that women consider the risks and ben-
efits of screening first, and base their decision on accurate
information. The use of decision aids to improve informed
decision making has been found to be promising in breast
and colorectal cancer screening, but more research is
needed to explore their use in the cervical screen-
ing context.28
Previous studies have suggested some commonly
described attitudes to screening, including being embar-
rassed, concerned about the test, and concerned about
the gender of the smear taker, do not directly influence
attendance.4,29 We also found that this was the case
when comparing those who have made different decisions
about screening, with the barriers ‘I am too embarrassed to
go for screening’, ‘I wouldn’t want a man to carry out the
Table 2. Odds of active decliners reporting each barrier to screening (compared with intenders).
Proportion endorsing each barrier n (%)
Unadjusted odds
ratio for being an
active decliner
Adjusted odds ratio
for being an active
declinerþ
All
N¼ 543
Intenders
N¼ 426
Active
decliners
N¼ 117
I am too old to go for screening 22 (4.1) 12 (2.8) 10 (8.5) 3.22 (1.36–7.66)** 2.04 (0.73–5.71)
I have other more important things to
worry about than screening
24 (4.4) 10 (2.3) 14 (11.9) 5.65 (2.44–13.09)*** 5.96 (2.21–16.1)***
I am too busy to go for screening 89 (16.4) 74 (17.4) 15 (12.8) 0.70 (0.39–1.27)
Low perceived relevance based on
sexual behaviour
82 (15.1) 50 (11.7) 32 (27.4) 2.83 (1.71–4.68)*** 3.07 (1.66–5.68)***
I am too embarrassed to go
for screening
63 (11.6) 48 (11.3) 15 (12.7) 1.16 (0.62–2.15)
I’m frightened of what the test
might find
52 (9.6) 45 (10.6) 7 (5.9) 0.54 (0.24–1.23)
I wouldn’t want a man to carry out the
screening test
44 (8.1) 34 (8) 10 (8.5) 1.08 (0.52–2.25)
I wouldn’t want anyone to know I had
been for screening
12 (2.2) 9 (2.1) 3 (2.5) 1.22 (0.33–4.58)
I’ve had a bad experience of screening
in the past
44 (8.1) 28 (6.6) 16 (13.6) 2.25 (1.17–4.32)* 1.87 (0.87–4.02)
I have weighed up the risks and benefits
and decided it’s not worth me going
for screening
19 (3.5) 4 (0.9) 15 (12.7) 15.52 (5.04–47.74)*** 11.53 (3.19–41.70)***
I haven’t been invited to cervi-
cal screening
66 (12.2) 61 (14.3) 5 (4.3) 0.27 (0.11–0.68)** 0.30 (0.10–0.91)*
þAdjusting for sociodemographic factors (age, marital status) and all significant barriers; *p< 0.05, **p< 0.01, ***p< 0.001.
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screening test’, ‘I wouldn’t want anyone to know I had
been for screening’, and ‘I’m frightened of what the test
might find’ endorsed by a similar proportion of intenders
and active decliners.
Most participants reported that they would ‘definitely’ or
‘probably’ prefer home-based self-sampling, and interest in
self-sampling was particularly high among those who were
too busy or too embarrassed to go for screening, wouldn’t
want a man to carry out the test, or had had a bad experi-
ence of screening in the past. Offering HPV self-sampling to
screening non-attenders, either by post, or opportunistically
in primary care, could be an effective strategy for increasing
participation among women who have decided not to
attend. A study conducted in the United Kingdom with per-
sistent non-responders (women who had not responded to at
least two invitations to attend for cervical screening), ran-
domized women to be posted either an HPV self-sampling
kit or a third invitation.30 In the self-sampling group 10%
returned their kit, and in the group sent an additional invi-
tation, 5% attended screening.30 Another study in the
United Kingdom offered self-sampling to cervical screening
non-attenders opportunistically when they attended a prima-
ry care appointment, and found that 9% returned a
self-sample.31
Our study benefits from using population-based data to
identify women who have made a decision about whether
to attend for cervical screening in the future. The data were
based on self-reported screening history, and while this
method is commonly used, participants may have overes-
timated screening utilization.32 In addition, some of the
barriers to screening were endorsed by small numbers of
participants, and therefore the study may not have been
adequately powered to detect differences between groups.
The barrier ‘I haven’t been invited to cervical screening’
was one of the most frequently endorsed across all age
groups, with most participants (61/66) who endorsed this
barrier reporting that they were intending to attend screen-
ing in the future. It is not clear why over 10% of
participants in our sample reported that they had not
received an invitation to be screened, as eligible women
should automatically be invited if they are registered
with a GP. Very few women reported that they were not
registered with a GP (n¼ 10). Written invitations sent by
post are becoming a less common method of communica-
tion,33 and some women may have received the invitation
but not read it. It is important that all women are made
aware that only those registered with a GP will be invited
to take part in screening. Another limitation is that we did
not have comparative data from women who were up to
date with cervical screening.
Conclusions
To our knowledge, this is the first study to compare bar-
riers to participation in cervical screening between women
who have made an active decision not to be screened in the
future and women who are intending to take part. Women
who actively decline screening tend to be older, unmarried,
and perceive screening as being of low personal relevance.
HPV self-sampling could address specific emotional and
practical barriers and is likely to be an acceptable alterna-
tive for screening non-attenders who have not been
screened in the conventional way.
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